Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19275136 | 0.67 | — | — | |
| SCHEMBL8431274 | 0.65 | ALDH1A1 (0.30) | ALDH1A1TSHR | |
| SCHEMBL7875815 | 0.65 | — | — | |
| SCHEMBL29344280 | 0.62 | — | — | |
| SCHEMBL7541032 | 0.61 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL1630402 | 0.61 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL3689919 | 0.61 | ALDH1A1 (0.46) | ALDH1A1TSHRMAPK1 | |
| SCHEMBL2507552 | 0.61 | TSHR (0.38) | ALDH1A1TSHR | |
| Isobutane SCHEMBL25273675 | 0.57 | — | — | |
| Methylene Chloride SCHEMBL5375622 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020010371-A1 | Process for preparing a cyclic amino acid anticonvulsant compound | DEERING CARL FRANCIS (US) | 2002-01-24 | — | — | US | claimed |
| US-6294690-B1 | REACTING BENZONITRILE WITH ALKALI METAL IN AMMONIA OR AMINE IN SOLVENT TO FORM ANIONIC INTERMEDIATE, ALKYLATING WITH HALOACETIC ACID, HYDROGENATING RING, HYDROGENATING NITRILE TO AMINE TO PRODUCE GABAPENTIN | WARNER-LAMBERT COMPANY | 2001-09-25 | — | — | US | claimed |
| WO-1999018063-A2 | PROCESS FOR PREPARING A CYCLIC AMINO ACID ANTICONVULSANT COMPOUND | WARNER-LAMBERT COMPANY (US) | 1999-04-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020010371-A1 | Process for preparing a cyclic amino acid anticonvulsant compound | BCAT1, BCAT2, GABRA6 | ALDH1A1 2115/4885TSHR 2643/4885MAPK1 1986/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.